TrialNature communications2018
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD
Christopher R Martens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
345 papers cite itlatest 60 shown
this paperpooled ittrialcites it